[e-drug] Why it is a good idea to extend the LDC medicines transition at the WTO

E-DRUG: Why it is a good idea to extend the LDC medicines transition at the WTO
----------------------------------------------------------------------------------------------------------

Dear e-drug readers,

Please find here the link to a brief piece I did for IP-watch on why it is a good idea to extend the transition period for the implementation of the WTO TRIPS obligations with regards to medicines patents and the protection of undisclosed data.

http://www.ip-watch.org/2015/02/27/why-the-request-by-least-developed-countries-for-an-extension-of-the-transitional-period-for-granting-and-enforcing-medicines-patents-needs-to-be-supported/

Kind regards,
Ellen